A detailed history of Letko, Brosseau & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 2,991,458 shares of PFE stock, worth $74.6 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
2,991,458
Previous 3,243,383 7.77%
Holding current value
$74.6 Million
Previous $90.7 Million 4.6%
% of portfolio
1.61%
Previous 1.77%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$27.7 - $31.39 $6.98 Million - $7.91 Million
-251,925 Reduced 7.77%
2,991,458 $86.6 Million
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $2.89 Million - $3.38 Million
114,285 Added 3.65%
3,243,383 $90.7 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $2.1 Million - $2.41 Million
80,930 Added 2.66%
3,129,098 $86.8 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $24.5 Million - $31.9 Million
938,933 Added 44.52%
3,048,168 $87.8 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $1.09 Million - $1.27 Million
33,990 Added 1.64%
2,109,235 $70 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $15.2 Million - $17.5 Million
419,502 Added 25.34%
2,075,245 $76.1 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $519,554 - $676,383
13,190 Added 0.8%
1,655,743 $67.6 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $1.16 Million - $1.51 Million
-27,722 Reduced 1.66%
1,642,553 $84.2 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $4.62 Million - $5.64 Million
-105,533 Reduced 5.94%
1,670,275 $73.1 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $7.5 Million - $8.89 Million
-161,175 Reduced 8.32%
1,775,808 $93.1 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $4.69 Million - $5.81 Million
-102,480 Reduced 5.02%
1,936,983 $100 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $2.91 Million - $4.31 Million
-70,315 Reduced 3.33%
2,039,463 $120 Million
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $5.84 Million - $7.51 Million
-148,905 Reduced 6.59%
2,109,778 $90.7 Million
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $28.5 Million - $32.3 Million
794,122 Added 54.22%
2,258,683 $88.5 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $1.32 Million - $1.49 Million
-39,375 Reduced 2.62%
1,464,561 $53.1 Million
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $5.2 Million - $6.61 Million
-155,410 Reduced 9.37%
1,503,936 $55.4 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $5.46 Million - $6.4 Million
-171,847 Reduced 9.38%
1,659,346 $60.9 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $3.09 Million - $3.75 Million
-102,630 Reduced 5.31%
1,831,193 $59.9 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $137,853 - $196,962
5,100 Added 0.26%
1,933,823 $63.1 Million
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $2.37 Million - $2.69 Million
-72,040 Reduced 3.6%
1,928,723 $75.6 Million
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $2.19 Million - $2.84 Million
-67,296 Reduced 3.25%
2,000,763 $71.9 Million
Q2 2019

Aug 01, 2019

SELL
$36.98 - $41.52 $5.12 Million - $5.75 Million
-138,390 Reduced 6.27%
2,068,059 $89.6 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $4.65 Million - $5.11 Million
-123,942 Reduced 5.32%
2,206,449 $93.7 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $21.6 Million - $24.6 Million
-560,256 Reduced 19.38%
2,330,391 $102 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $25.9 Million - $31.4 Million
-751,627 Reduced 20.64%
2,890,647 $127 Million
Q2 2018

Aug 07, 2018

SELL
$32.98 - $35.16 $2.89 Million - $3.08 Million
-87,610 Reduced 2.35%
3,642,274 $132 Million
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $4.77 Million - $5.53 Million
-149,380 Reduced 3.85%
3,729,884 $132 Million
Q4 2017

Feb 20, 2018

SELL
$33.26 - $35.29 $6.13 Million - $6.5 Million
-184,243 Reduced 4.53%
3,879,264 $141 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $126 Million - $139 Million
4,063,507
4,063,507 $145 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.